Previous studies have revealed that the occurrence of NA is related to factors such as stent implantation time, stent type, current smoking status, chronic kidney disease (CKD), and the use of angiotensin-converting enzyme inhibitor/angiotensin receptor blocker (ACEI/ARB) [1, 5, 6]. This evidence concerns the gene ACE and chronic kidney disease.